click below
click below
Normal Size Small Size show me how
Onc
Onc-oncogenes and suppressors
| Question | Answer |
|---|---|
| abl | CML, oncogene |
| c-myc | burkitt's lymphoma, oncogene |
| bcl-2 | follicular and undifferentiated lymphoma (inhibits apoptosis), oncogene |
| erb-B2 | breast, ovarian, and gastric carcinoma, oncogene |
| ras | colon carcinoma, oncogene |
| L-myc | Lung tumor, oncogene |
| N-myc | Neuroblastoma |
| ret | multiple endocrine neoplasia (MEN) types I and II, oncogene |
| Rb | chrom 13q, tumor suppressor, retinoblastoma, osteosarcoma. suppresses G1 -->S by inactivating EF2 |
| BRCA 1 and 2 | 17q, 13q. tumor suppresor gene, breast and ovarian cancer |
| p53 | 17p, tumor suppressor gene, activates apoptosis, most human cancers, Li-Fraumeni syndrome |
| p16 | 9p, tumor suppressor gene, melanoma |
| APC | 5q, tumor suppressor gene, colorectal cancer |
| WT1 | 11q, Wilms' tumor, tumor suppressor gene |
| NF1 | 17q, tumor suppressor gene, Neurofibromatosis type 1 |
| NF2 | 22q, tumor suppressor gene, Neurofibromatosis type 2 |
| DPC | 18q, tumor suppressor gene, pancreatic cancer |
| DCC | 18q, tumor suppressor gene, colon cancer |
| PSA (prostatic acid phosphatase) | prostate specific antigen, prostatic carcinoma, used for screening |
| CEA | carcinoembyronic antigen. very nonspecific but make by about 70% of colorectal and pancreatic cancers; also produced by gastric and breast carcinomas |
| a-fetoprotein | fetus (normal). hepatocellular carcinomas. nenseminomatous germ cell tumors of the testis (eg yolk sac tumor) |
| B-hCG | Hyaditidorm mole, choriocarcinoma, gestational trophoblastic tumors |
| CA-125 | ovarian, malignant epithelial tumors |
| S-100 | melanoma, neural tumors, astrocytoma |
| alkaline phosphatase | metastases to bone, obstructive biliary disease, Paget's disease of bone |
| bombesin | neuroblastoma, lung and gastric cancer |
| TRAP | Tartrate-resistant acid phosphatase. hair cell leukemia, a B cell neoplasm |
| t(9;22) | Philadelphia chromosome, CML (bcr-abl hybrid) |
| t(8;14) | Burkitt's lymphoma, c-myc activation |
| t(14;18) | follicular lymphoma (bcl-2 activation) |
| t(15;17) | M3 type of AML (responsive to all trans retinoic acid). translocation of retinoic acid receptor |
| t(11;22) | Ewing's sarcoma |
| t(11;14) | Mantle cell lymphoma. overexpression of cyclins rushes cell through cycle and results in hyperproliferation. |
| Hodgkin's therapy ABVD | adriamycin (doxorubicin), bleomycin, vincristine, dexamethasone |
| Hodgkin's therapy MOPP | mustard, oncovin (vincristine), procarbazine, prednisone |
| T cell marker | CD 1-8 |
| B cell marker | CD 10, 19-23 |
| Mono, mac marker | CD 13, 14, 15, 33 |
| Stem cell | CD 34 |
| ALL marker | CD 45 |
| NK marker | CD 16, 56 |
| B Cell ALL marker | CD 10, 19, 20 |
| T Cell ALL Marker | CD1 and Pan T |
| CLL marker | CD 5, 23 |